Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(337)
•••
Comment by jayjay2020on Oct 14, 2019 11:34am
178 Views
Post# 30228295

RE:RE:RE:RE:RE:I saw someone post

RE:RE:RE:RE:RE:I saw someone post
ProfCornelius wrote: Revs are incorrect. They will be lower. Two. EBITDA will be positive. Correct. HC approval of Aphria Diamond will not be this Friday. Incorrect. Remember this post people because tomorrow will be shocking in a positive way for most of you is all I can say. You scored 33% outhere but I applaud you for manning up. Can't wait for tomorrow. Only then will most of you understand how cryptic this post really was. PROF
Outhere wrote: I have said all along that earnings in Q1 will be fine.  

Rev $136 to $145mm
EBITDA will be positive
And yes I do think HC DD approval will come this month, sure go with this Friday.




Prof is correct. I only respectfully disagree with revs not beating. Rev $143-$150M is my call. Everything else he is right.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities